Compare HTHT & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTHT | DAWN |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 624.8M |
| IPO Year | 2010 | 2021 |
| Metric | HTHT | DAWN |
|---|---|---|
| Price | $48.49 | $9.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $47.00 | $26.56 |
| AVG Volume (30 Days) | 1.2M | ★ 2.9M |
| Earning Date | 11-17-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | ★ 7.24 | N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $3,484,239,807.00 | $133,672,000.00 |
| Revenue This Year | $7.12 | $15.51 |
| Revenue Next Year | $6.64 | $49.99 |
| P/E Ratio | $27.59 | ★ N/A |
| Revenue Growth | 5.77 | ★ 31.11 |
| 52 Week Low | $30.13 | $5.64 |
| 52 Week High | $49.49 | $13.53 |
| Indicator | HTHT | DAWN |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 58.46 |
| Support Level | $48.06 | $8.13 |
| Resistance Level | $49.49 | $9.82 |
| Average True Range (ATR) | 1.04 | 0.59 |
| MACD | -0.17 | 0.10 |
| Stochastic Oscillator | 70.84 | 64.40 |
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.